Press Releases

Date	Title	Company
30-Mar-2022	Home Sleep Screening Devices Market Expanding at a healthy 8.5% CAGR in the Forecast period of 2022-2028	MARKITWIRED
30-Mar-2022	Atopic Dermatitis Treatment Market was valued at US$ 5.2 Billion in 2021 and is expected to reach US$ 7.6 Billion by 2029	MARKITWIRED
30-Mar-2022	Multiplex Biomarker Imaging Market by Component Type: Instruments, Software and Services, Forecast to 2022-2030	MARKITWIRED
30-Mar-2022	STRATEC SE: STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEAR	STRATEC SE
30-Mar-2022	Radiotherapy Patient Positioning Accessories Market Getting New Opportunities with the Top Companies: CIVCO Radiation, Orfit Industries N.V., IZI Medical Products, Klarity Medical Products-2022-2028	MARKITWIRED
30-Mar-2022	Oscillating Positive Expiratory Pressure (OPEP) Devices Market valuation is Expected to Reach USD 195.2 Million in period of 2022-2029	MARKITWIRED
29-Mar-2022	Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG	Formycon AG
29-Mar-2022	Formycon and ATHOS KG merge development activities through the acquisition of biosimilar assets in a long-term strategic partnership	Formycon AG
29-Mar-2022	Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration	Rentschler Biopharma
29-Mar-2022	Teledyne Princeton Instruments announces new series of CCD cameras for Original Equipment Manufacturers	Teledyne Princeton Instruments
29-Mar-2022	Qure.ai raises $40 Million from healthcare investors Novo Holdings and HealthQuad	Qure.ai
29-Mar-2022	Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration	B3C newswire
29-Mar-2022	Hansa Biopharma and Medison Pharma announce marketing authorization in Israel for Idefirix® (imlifidase) for desensitization treatment of highly sensitized kidney transplant patients	Hansa Biopharma
29-Mar-2022	Freya Pharma Solutions secures US$8.5 million enabling the start of a pivotal phase 3 trial with Lybrido against Female Sexual Interest/Arousal Disorder (FSIAD)	Freya Pharma Solutions
29-Mar-2022	Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors	AstraZeneca
29-Mar-2022	eTheRNA Manufacturing Announces New LNP Formulation Development and Production Service	eTheRNA Manufacturing
29-Mar-2022	Ebvia Announces Positive Results Published in Nature for TMPRSS2 Inhibitor for the Prevention and Treatment of COVID-19	Newswire
29-Mar-2022	Longwood Fund Announces Longwood Healthcare Leaders, a Web Conference for Industry Leaders, on May 4-5, 2022	Newswire
29-Mar-2022	Rejuvenate Biomed Started a Groundbreaking Clinical Trial and Expands for Future Growth	Rejuvenate Biomed
29-Mar-2022	Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy	Santhera Pharmaceuticals